← TURKCELL ILETISIM HIZMETLERI A S TKC
Market Price
$5.48
Market Cap
$4.73B
P/E Ratio
0.68
Revenue (FY 2025)
↑44.9% YoY
$241.47B
3-Yr CAGR: 57.7%
Net Income
↑205,682.2% YoY
$17.60B
Net Margin: 7.3%
Free Cash Flow
↑61.7% YoY
$52.65B
FCF Yield: 1,113.28%
EPS (Diluted)
↓-25.1% YoY
$8.08
Basic: $8.08
Return on Equity
Efficiency
6.8%
ROA: 3.5%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (TKC)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $14,100.9M | — | $4,934.5M | $51.7M | — | $0.68 | — | $607.1M | $-1,965.3M | — |
| FY 2017 | $17,026.4M | +20.7% | $5,952.9M | $58.6M | +13.4% | $0.90 | +32.4% | $3,101.3M | $164.1M | +108.3% |
| FY 2018 | $21,292.5M | +25.1% | $6,565.1M | $156.3M | +166.5% | $0.93 | +3.3% | $5,829.9M | $2,869.2M | +1,648.8% |
| FY 2019 | $25,137.1M | +18.1% | $7,179.6M | $30.2M | -80.7% | $1.49 | +60.2% | $9,026.6M | $5,831.5M | +103.2% |
| FY 2020 | $29,103.7M | +15.8% | $8,111.7M | $2.5M | -91.6% | $1.94 | +30.2% | $13,092.8M | $9,188.4M | +57.6% |
| FY 2021 | $35,920.5M | +23.4% | $9,966.5M | $0.2M | -92.9% | $2.30 | +18.6% | $19,947.2M | $14,378.9M | +56.5% |
| FY 2022 | $61,544.3M | +71.3% | $7,341.2M | $-1.0M | -632.8% | $1.90 | -17.4% | $25,459.6M | $16,274.9M | +13.2% |
| FY 2023 | $107,116.2M | +74.0% | $20,722.5M | $-21.8M | -2,168.0% | $5.75 | +202.6% | $41,721.5M | $27,504.8M | +69.0% |
| FY 2024 | $166,671.4M | +55.6% | $38,419.8M | $-8.6M | +60.6% | $10.79 | +87.7% | $63,257.1M | $32,558.3M | +18.4% |
| FY 2025 | $241,470.8M | +44.9% | $64,297.6M | $17,604.0M | +205,682.2% | $8.08 | -25.1% | $96,619.6M | $52,651.7M | +61.7% |
Valuation
Market Price
$5.48
Market Cap
$4.73B
Enterprise Value
N/A
P/E Ratio
0.68
P/B Ratio
0.02
FCF Yield
1,113.28%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
26.63%
Operating Margin
15.87%
Net Margin
7.29%
Return on Equity (ROE)
6.79%
Return on Assets (ROA)
3.52%
Asset Turnover
0.48x
Revenue 3-Yr CAGR
57.72%
Financial Health & Liquidity
Current Ratio
4.56
Cash Ratio
47.01
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
$91.83B
Total Debt
N/A
Book Value / Share
$297.75
Cash Flow Efficiency
Operating Cash Flow
$96.62B
Capital Expenditures (CapEx)
$43.97B
Free Cash Flow
$52.65B
OCF / Revenue
40.01%
FCF / Revenue
21.80%
FCF 3-Yr CAGR
47.90%
Per Share Metrics
EPS (Diluted)
$8.08
EPS (Basic)
$8.08
Dividends / Share
N/A
Book Value / Share
$297.75
EPS YoY Growth
-25.12%
Balance Sheet (FY 2025)
Total Assets
$500.57B
Total Liabilities
$241.24B
Stockholders' Equity
$259.33B
Current Assets
$8.90B
Current Liabilities
$1.95B